- Home
- NATR
as 06-24-2025 4:00pm EST
Natures Sunshine Products Inc is a natural health and wellness company, predominantly engaged in the manufacturing and selling of nutritional and personal care products. It offers products related to Weight management, General health, Cardiovascular, Digestive, Immune, and Personal care. The company operates in four segments namely, Asia which is also its key revenue generating market, Europe, North America, Latin America, and Other.
| Founded: | 1972 | Country: | United States |
| Employees: | N/A | City: | LEHI |
| Market Cap: | 269.6M | IPO Year: | N/A |
| Target Price: | $18.50 | AVG Volume (30 days): | 65.5K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.53 | EPS Growth: | -37.88 |
| 52 Week Low/High: | $10.80 - $18.06 | Next Earning Date: | 08-07-2025 |
| Revenue: | $456,619,000 | Revenue Growth: | 2.00% |
| Revenue Growth (this year): | 3.08% | Revenue Growth (next year): | 2.41% |
Latest Nature's Sunshine Products Inc. News
NATR Breaking Stock News: Dive into NATR Ticker-Specific Updates for Smart Investing
StockStory
5 days ago
1 Cash-Producing Stock with Solid Fundamentals and 2 to Avoid
StockStory
8 days ago
3 Reasons to Avoid NATR and 1 Stock to Buy Instead
GlobeNewswire
16 days ago
Nature’s Sunshine Renews Scholarship Fund with Eccles School of Business
StockStory
20 days ago
1 Safe-and-Steady Stock with Exciting Potential and 2 to Question
StockStory
21 days ago
Reflecting On Personal Care Stocks’ Q1 Earnings: USANA (NYSE:USNA)
StockStory
23 days ago
Why Nature's Sunshine (NATR) Shares Are Falling Today
MT Newswires
23 days ago
Nature's Sunshine Products CEO Moorehead to Step Down; Shares Fall
GlobeNewswire
23 days ago
Nature’s Sunshine Announces Leadership Transition Plan
Compare NATR vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "NATR Nature's Sunshine Products Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.